These findings strongly suggest that the increased CapG expression significantly associated with decreased sensitivity to PTX chemotherapy, and may predict decreased chance of achieving pCR in breast cancer patients receiving PTX regimen chemotherapy. Here, CAPG is linked to breast carcinoma.